methotrexate has been researched along with Pulmonary Veno Occlusive Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdel-Rahman, F; Adil, SN; Ahmed, P; Alabdulaaly, A; Alimoghaddam, K; Aljurf, M; Alseraihy, A; Bazarbachi, A; Bekadja, MA; Ben Othman, T; Benchekroun, S; Dennison, D; Elhaddad, A; Ghavamzadeh, A; Hamidieh, A; Hamladji, R; Hussain, F; Ibrahim, A; Jarrar, M; Mohamed, SY; Ramzi, M; Rasheed, W | 1 |
1 other study(ies) available for methotrexate and Pulmonary Veno Occlusive Disease
Article | Year |
---|---|
Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey.
Topics: Academies and Institutes; Anti-Infective Agents; Cyclosporine; Data Collection; Graft vs Host Disease; Growth Hormone; Hematopoietic Stem Cell Transplantation; Humans; Mediterranean Region; Methotrexate; Pulmonary Veno-Occlusive Disease; Transplantation, Autologous; Transplantation, Homologous; Ursodeoxycholic Acid | 2013 |